✦ LIBER ✦

Combination versus sequential single agent chemotherapy in advanced breast cancer: associations with metastatic sites and long-term survival

✍ Scribed by Chlebowski, RT; Smalley, RV; Weiner, JM; Irwin, LE; Bartolucci, AA; Bateman, JR

Book ID: 109836304
Publisher: Nature Publishing Group
Year: 1989
Tongue: English
Weight: 858 KB
Volume: 59
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1989.46

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination versus sequential single-age

Combination versus sequential single-agent chemotherapy in the treatment of patients with advanced non-small cell lung cancer

✍ Niell, Harvey B. ;Griffin, John P. ;Hunter, Robert F. ;Meredith, Charlotte A. ;S 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB

We have carried out a randomized phase Ill study in 105 patients with advanced nonsmall cell lung cancer, comparing a fourdrug cisplatin-mitomycin-based combination chemotherapy regimen t o sequential single-agent therapy. The combination chemotherapy regimen consisted of mitomycin C (10 mg/m2), vin

Single agent versus combination chemothe

Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma : A meta-analysis of response, toxicity, and survival

✍ Rogerio C. Lilenbaum; Patricia Langenberg; Kay Dickersin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 2 views

## Background: This meta-analysis was conducted to compare the effects of single agent versus combination chemotherapy on response rate, toxicity, and survival of patients with advanced nonsmall cell lung carcinoma (nsclc). ## Methods: The authors reviewed randomized clinical trials published in

Long-term survival with advanced ovarian

Long-term survival with advanced ovarian cancer: An analysis of 5-year survivors in the Australian trial comparing combination versus sequential chlorambucil and cisplatin therapy

✍ M.H.N. Tattersall; C.E. Swanson; H.J. Solomon 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 597 KB

Five-year survival for cisplatin-based c

Five-year survival for cisplatin-based chemotherapy versus single-agent melphalan in patients with advanced ovarian cancer and optimal debulking surgery

✍ M. Steven Piver; James Fanning; Henry E. Sprance 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

The purpose of this study was to evaluate 5-year survival and 5-year progression-free survival in previously untreated patients with advanced ovarian cancer treated with single-agent melphalan in which very few patients underwent optimal debulking surgery (<2 cm residual) as compared with the patien

Long-term LHRH-agonist treatment in meta

Long-term LHRH-agonist treatment in metastatic breast cancer as a single treatment and in combination with other additive endocrine treatments

✍ Jan G. M. Klijn 📂 Article 📅 1984 🏛 Springer US 🌐 English ⚖ 374 KB

A phase 2 study of sequential neoadjuvan

A phase 2 study of sequential neoadjuvant chemotherapy with gemcitabine and doxorubicin followed by gemcitabine and cisplatin in patients with large or locally advanced operable breast cancer: results from long-term follow-up

✍ Julka, Pramod K.; Chacko, Raju T.; Nag, Shona; Parshad, Rajinder; Nair, Aravinda 📂 Article 📅 2012 🏛 Springer Japan 🌐 English ⚖ 244 KB